INSIGHTS ON CLINICAL TRIAL DESIGN

• The Difference Between Clinical Trial Auditing And Monitoring

  While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• Inspection Facilitation Without Local MAH Presence

  Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.

• Advancing Dose Escalation Strategies With Bayesian Modeling

  A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.

• Managing Drug And Data Requirements In Decentralized Clinical Trials

  9/15/2025

  Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.

• Why Early Clinical Development Is Shifting Toward Decision-Enabling Study Designs

  6/9/2026

  Early clinical research is shifting to decision-focused designs, using biomarkers, functional endpoints, and targeted populations to reduce uncertainty and enable clearer progression.

• Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials

  3/12/2026

  Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.

• GA Screening: Early Detection For Future Trial Recruitment

  4/9/2026

  Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.

• Patient Liaison Support In Rare Disease Trials

  2/11/2026

  Real stories from rare disease trials show how attentive communication, logistical coordination, and timely reimbursement reduce stress for participants while keeping long-term engagement.